Historical record - last NADAC effective date: 2/21/2024

Product Information

PREGABALIN 25 MG CAPSULE is a generic product labeled by Cipla USA Inc., priced at $0.0657 per EA under NDC 69097095405. Its NADAC has been published 236 times since Aug 21, 2019.

FDA first approved this application on Jul 19, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PREGABALIN 25 MG CAPSULE

PREGABALIN
$0.0657per EA
DEA Schedule CV

Strength

25 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097095405

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

2/21/2024

Active Ingredients

PREGABALIN

Approval Type

Generic (ANDA)

FDA Application

ANDA211384

FDA Approved

7/19/2019

TE Code

AB

On Market Since

7/19/2019

Price Statistics

The NADAC for PREGABALIN 25 MG CAPSULE has been published 236 times since Aug 21, 2019, and over the history we have for it it has declined 55.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0657 per EA
All-time high$0.1486 (Sep 11, 2019)
All-time low$0.0511 (Oct 18, 2023)
Median price$0.0878
Average price$0.0941
Largest weekly change-26.0% (Sep 20, 2023)
Weeks tracked236
Tracking sinceAug 21, 2019

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

-10.2%

5Y

-31.1%

All

-55.8%

Last surveyed Feb 21, 2024 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 38% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of PREGABALIN 25 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for PREGABALIN 25 MG CAPSULE, manufactured by Cipla USA Inc., is $0.0657 per EA (NDC 69097095405), effective Feb 21, 2024.

How has the price of PREGABALIN 25 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for PREGABALIN 25 MG CAPSULE has declined 55.8%. It has been tracked across 236 weekly CMS publications since Aug 21, 2019.

What are the highest and lowest recorded NADAC prices for PREGABALIN 25 MG CAPSULE?

Since Aug 21, 2019, the NADAC for PREGABALIN 25 MG CAPSULE has ranged from a low of $0.0511 (Oct 18, 2023) to a high of $0.1486 (Sep 11, 2019), with a median of $0.0878 per EA.

Are there cheaper alternatives to PREGABALIN 25 MG CAPSULE?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PREGABALIN 25 MG CAPSULE, is $0.0406 per EA — about 38% below PREGABALIN 25 MG CAPSULE.

Who manufactures PREGABALIN 25 MG CAPSULE?

PREGABALIN 25 MG CAPSULE (NDC 69097095405) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.